Anticancer Research: 42 (12)

December 2022; Volume 42,Issue 12

Review

You have access
Phase I CAR-T Clinical Trials Review
SHAUN BULSARA, MENGFEN WU and TAO WANG

Anticancer Research December 2022, 42 (12) 5673-5684; DOI: https://doi.org/10.21873/anticanres.16076

Experimental Studies

Open Access
In Vitro Anticancer Activity of the Light Stable Zinc Isotope (⁶⁴Zn) Compounds
PETER NOVAK, ALEXANDR BALAKIN and MAX TEMNIK

Anticancer Research December 2022, 42 (12) 5685-5698; DOI: https://doi.org/10.21873/anticanres.16077
Open Access
The Prognostic Value of Plasma Small Extracellular Vesicles’ Phenotype in Patients With Gastrointestinal Stromal Tumor
CHARLOTTE M. BRINCH, ESTRID HOGDALL, PIETER DE HEER, LUIT PENNINGA, RIKKE BÆK, MALENE M. JORGENSEN, BODIL E. ENGELMANN, PHILIP B. ROSSEN, HELENE J. MORTENSEN, ANDERS KRARUP-HANSEN and NINNA AGGERHOLM-PEDERSEN

Anticancer Research December 2022, 42 (12) 5699-5717; DOI: https://doi.org/10.21873/anticanres.16078
Open Access
GPX4 Regulates Tumor Cell Proliferation via Suppressing Ferroptosis and Exhibits Prognostic Significance in Gastric Cancer
KEN SUGEZAWA, MASAKI MORIMOTO, MANABU YAMAMOTO, YOSHIAKI MATSUMI, YUJI NAKAYAMA, KAZUSHI HARA, CHIHIRO UEJIMA, KYOICHI KIHARA, TOMOYUKI MATSUNAGA, NARUO TOKUYASU, TERUHISA SAKAMOTO, YOSHIHISA UMEKITA and YOSHIYUKI FUJIWARA

Anticancer Research December 2022, 42 (12) 5719-5729; DOI: https://doi.org/10.21873/anticanres.16079
Open Access
The Expression of Histone Acetyltransferase KAT6A in Non-small Cell Lung Cancer
ALEKSANDRA PARTYNSKA, ALEKSANDRA PIOTROWSKA, KONRAD PAWELCZYK, ADAM RZECHONEK, KATARZYNA RATAJCZAK-WIELGOMAS, MARZENNA PODHORSKA-OKOLOW and PIOTR DZIEGIEL

Anticancer Research December 2022, 42 (12) 5731-5741; DOI: https://doi.org/10.21873/anticanres.16080
You have access
Intracellular C3 Modulates EMT via the Akt/Smad Pathway in Pancreatic Cancer Cells
REI SUZUKI, TADAYUKI TAKAGI, MITSURU SUGIMOTO, YUKI SATO, HIROKI IRIE, YUKI YOMOGIDA and HIROMASA OHIRA

Anticancer Research December 2022, 42 (12) 5743-5750; DOI: https://doi.org/10.21873/anticanres.16081
You have access
Immunohistochemical Analysis of Common Cancer Antigens in Head and Neck Squamous Cell Carcinoma
YOHEI MORISHITA, KAZUMASA TAKENOUCHI, SHINGO SAKASHITA, KAZUTO MATSUURA, RYUICHI HAYASHI and TETSUYA NAKATSURA

Anticancer Research December 2022, 42 (12) 5751-5761; DOI: https://doi.org/10.21873/anticanres.16082
You have access
Endosomal Localization of RacGAP Protein ARHGAP22 Regulates its GAP Activity in Human Melanoma Cells
MAMIKO MORI, KOJI SAITO, AYANO SEKINE, RIO HASEBE and YASUTAKA OHTA

Anticancer Research December 2022, 42 (12) 5763-5771; DOI: https://doi.org/10.21873/anticanres.16083
Open Access
COX-2 Acts as a Key Mediator of Trifluoperazine-induced Cell Death in U87MG Glioma Cells
JUYEONG PARK, JOO YEON JEONG and SANG SOO KANG

Anticancer Research December 2022, 42 (12) 5773-5781; DOI: https://doi.org/10.21873/anticanres.16084
You have access
Chronological Change in EPHA2 Protein Expression Is Associated With Recurrence of Bladder Cancer
MITSUYUKI KOIZUMI, SHINYA SATO, MITSUYO YOSHIHARA, YOSHIYASU NAKAMURA, HIDEYUKI TERAO, YOICHIRO OKUBO, KOTA WASHIMI, EMI YOSHIOKA, TOMOYUKI YOKOSE, TAKESHI KISHIDA, NAOHIKO KOSHIKAWA and YOHEI MIYAGI

Anticancer Research December 2022, 42 (12) 5783-5794; DOI: https://doi.org/10.21873/anticanres.16085
You have access
Genetic Predisposition to Male Breast Cancer: A Case Series
ANGELA APESSOS, KONSTANTINOS AGIANNITOPOULOS, GEORGIA PEPE, GEORGIOS N. TSAOUSIS, PANAGIOTA PITTA, CHRYSANTHI BILI, LINA FLORENTIN, EMMANOUEL SALOUSTROS, ELEFTHERIOS KAMPLETSAS, DIMITRIOS TRYFONOPOULOS, NIKOLAOS TSOUKALAS, EVANGELOS BOURNAKIS, FLORA ZAGOURI, ATHANASSIOS KOTSAKIS, ANNA KOUMARIANOU, IPPOKRATIS KORANTZIS, IOANNIS BOUKOVINAS, GEORGE LYPAS, GEORGIOS FOUNTZILAS, VASILIKI MICHALAKI, SPYRIDON XYNOGALOS, HELENA LINARDOU, EIRINI PAPADOPOULOU, GEORGE NASIOULAS and VASSILIS GEORGOULIAS

Anticancer Research December 2022, 42 (12) 5795-5801; DOI: https://doi.org/10.21873/anticanres.16086
You have access
Hypoxia Increases the Proliferative and Metastatic Ability of Canine Mammary Tumor Cells via Up-regulation of TSG-6
TAE-HYEON KIM, JEONG-HWA LEE, JU-HYUN AN, BYUNG-GEE KO, KYEONG-BO KIM and HWA-YOUNG YOUN

Anticancer Research December 2022, 42 (12) 5803-5812; DOI: https://doi.org/10.21873/anticanres.16087

Clinical Studies

Open Access
Disparities in Time to Treatment for Breast Cancer
KULKAEW SUKNIAM, ALI ABBASZADEH KASBI, MOHAMMED ALI ASHARY, KYLE POPP, KRISTOPHER ATTWOOD, ANTHONY GEORGE and EMMANUEL GABRIEL

Anticancer Research December 2022, 42 (12) 5813-5818; DOI: https://doi.org/10.21873/anticanres.16088
Open Access
Elimination of Axillary-Lymph-Node Metastases in a Patient With Invasive Lobular Breast Cancer Treated by First-line Neo-adjuvant Chemotherapy Combined With Methionine Restriction
YUTARO KUBOTA, QINGHONG HAN, NORIYUKI MASAKI, CHIHIRO HOZUMI, KAZUYUKI HAMADA, YUSUKE AOKI, KOYA OBARA, TAKUYA TSUNODA and ROBERT M. HOFFMAN

Anticancer Research December 2022, 42 (12) 5819-5823; DOI: https://doi.org/10.21873/anticanres.16089
Open Access
Autologous and Allogeneic Stem Cell Transplantation as Salvage Treatment Options for Relapsed/Refractory Multiple Myeloma: A Single-center Experience over 20 Years
NORMANN STEINER, PAULA SCHOBER, WOLFGANG WILLENBACHER, BRIGITTE KIRCHER, EBERHARD GUNSILIUS, DOMINIK WOLF and DAVID NACHBAUR

Anticancer Research December 2022, 42 (12) 5825-5832; DOI: https://doi.org/10.21873/anticanres.16090
Open Access
Significance of Zinc Replacement Therapy After Pancreaticoduodenectomy
CHIE TAKISHITA, YUICHI NAGAKAWA, HIROAKI OSAKABE, NOBUHIKO NAKAGAWA, YUSUKE MITSUKA, JUNICHI MAZAKI, KENICHI IWASAKI, TETSUO ISHIZAKI and SHINGO KOZONO

Anticancer Research December 2022, 42 (12) 5833-5837; DOI: https://doi.org/10.21873/anticanres.16091
You have access
Evaluation of the Diagnostic Potential of Circulating MicroRNAs miR-1 and miR-21 in Patients With Ovarian Cancer
DAMIAN J. RALSER, MATEJA CONDIC, EVA EGGER, DOMINIQUE KOENSGEN, ALEXANDER MUSTEA and MATTHIAS B. STOPE

Anticancer Research December 2022, 42 (12) 5839-5845; DOI: https://doi.org/10.21873/anticanres.16092
You have access
Efficacy of Chemotherapy Plus Bevacizumab in Recurrent Glioblastoma Multiform: A Real-life Study
ALEXANDRE BEIGE, FRANÇOIS GHIRINGHELLI, JULIE LECUELLE, CAROLINE TRUNTZER, GILLES TRUC, JULIE VINCENT, WALID FARAH, FRANÇOIS BORSOTTI, IRINA MAZILU and SILVIA MIHAELA ILIE

Anticancer Research December 2022, 42 (12) 5847-5858; DOI: https://doi.org/10.21873/anticanres.16093
You have access
Predicting Overall Survival Using Machine Learning Algorithms in Oral Cavity Squamous Cell Carcinoma
JIA YAN TAN, JOHN ADEOYE, PETER THOMSON, DILEEP SHARMA, POORNIMA RAMAMURTHY and SIU-WAI CHOI

Anticancer Research December 2022, 42 (12) 5859-5866; DOI: https://doi.org/10.21873/anticanres.16094
You have access
Detection of “Incidentalomas” on Brain and Body ⁶⁸Ga-DOTATOC-PET Scans: A Retrospective Study and Case Illustration
GIUSEPPE EMMANUELE UMANA, GIANLUCA FERINI, MANDARA MURALIDHAR HARIKAR, TEJAS VENKATARAM, ROBERTA COSTANZO, GIANLUCA SCALIA, PAOLO PALMISCIANO, LARA BRUNASSO, FEDERICA PAOLINI, ANDREA SCIORTINO, ROSARIO MAUGERI, ANTONIO CREA, FABIO BARONE, FRANCESCO INSERRA, VALERIO DA ROS, GIACOMO CUTTONE, GABRIELE CORSALE, CONCETTO CRISTAUDO, SEBASTIANO COSENTINO, MARIA GABRIELLA SABINI and MASSIMO IPPOLITO

Anticancer Research December 2022, 42 (12) 5867-5873; DOI: https://doi.org/10.21873/anticanres.16095
Open Access
A Machine Learning Approach Using PET/CT-based Radiomics for Prediction of PD-L1 Expression in Non-small Cell Lung Cancer
CHAE HONG LIM, YOUNG WHA KOH, SEUNG HYUP HYUN and SU JIN LEE

Anticancer Research December 2022, 42 (12) 5875-5884; DOI: https://doi.org/10.21873/anticanres.16096
You have access
Clinical Significance of SEC11A Expression in Patients With Locally Advanced Gastric Cancer
HIDEAKI SUEMATSU, KENTARO SAKAMAKI, NAOHIDE OUE, YUKIHIKO HIROSHIMA, YAYOI KIMURA, SHIZUNE ONUMA, ITARU HASHIMOTO, SHINSUKE NAGASAWA, TORU AOYAMA, TAKANOBU YAMADA, HIROSHI TAMAGAWA, TAKASHI OGATA, YASUSHI RINO, MUNETAKA MASUDA, WATARU YASUI, YOHEI MIYAGI and TAKASHI OSHIMA

Anticancer Research December 2022, 42 (12) 5885-5890; DOI: https://doi.org/10.21873/anticanres.16097
Open Access
Further Study on Field Cancerization in the Human Colon
CARLOS A. RUBIO, CORINNA LANG-SCHWARZ and MICHAEL VIETH

Anticancer Research December 2022, 42 (12) 5891-5895; DOI: https://doi.org/10.21873/anticanres.16098
You have access
Fibroblast Activation Protein and Tertiary Lymphoid Structure in Colorectal Cancer Recurrence
SHIMON HAYASE, NORIKATSU MIYOSHI, SHIKI FUJINO, MASAYOSHI YASUI, MASAYUKI OHUE, SOICHIRO MINAMI, SHINYA KATO, AYUMI NAGAE, YUKI SEKIDO, TSUYOSHI HATA, ATSUSHI HAMABE, TAKAYUKI OGINO, HIDEKAZU TAKAHASHI, MAMORU UEMURA, HIROFUMI YAMAMOTO, YUICHIRO DOKI and HIDETOSHI EGUCHI

Anticancer Research December 2022, 42 (12) 5897-5907; DOI: https://doi.org/10.21873/anticanres.16099
You have access
Simultaneously Integrated Boost Affects Survival in Locally Advanced p16-Negative Oropharyngeal Squamous Cell Carcinoma
FRANCESCA DE FELICE, DANIELA MUSIO, MARIA SERPONE, GIANMARCO VAVALLE, CLAUDIA MARCHETTI and VINCENZO TOMBOLINI

Anticancer Research December 2022, 42 (12) 5909-5915; DOI: https://doi.org/10.21873/anticanres.16100
You have access
Evaluation of Lung Toxicity With Lenalidomide Using the Pharmacovigilance Database
JUNYA SATO, TSUCHIYA EREN, SAEKO MURATA, TADASHI SHIMIZU and MAYAKO UCHIDA

Anticancer Research December 2022, 42 (12) 5917-5925; DOI: https://doi.org/10.21873/anticanres.16101
You have access
Low Expression of SNAI1 in Lymph Node Metastasis Indicates Delayed Recurrence of Colonic Cancer
SUKCHOL LIM, KAZUSHIGE KAWAI, HIROAKI NOZAWA, KAZUHITO SASAKI, KOJI MURONO, SHIGENOBU EMOTO, YUICHIRO YOKOYAMA, HIROYUKI MATSUZAKI, YUZO NAGAI, SHINYA ABE, YUICHIRO YOSHIOKA, TAKAHIDE SHINAGAWA, HIROFUMI SONODA and SOICHIRO ISHIHARA

Anticancer Research December 2022, 42 (12) 5927-5935; DOI: https://doi.org/10.21873/anticanres.16102
You have access
Limited Oncological Benefits of Laparoscopic Total Gastrectomy With Splenectomy for Patients With Type 4 or Large Type 3 Gastric Cancer
MASAZUMI SAKAGUCHI, HISAHIRO HOSOGI, SHIGEO HISAMORI, YOSUKE KINJO, SEIICHIRO KANAYA and KAZUTAKA OBAMA

Anticancer Research December 2022, 42 (12) 5937-5944; DOI: https://doi.org/10.21873/anticanres.16103
You have access
Effect of Secondary Prophylactic G-CSF on the Occurrence of Febrile Neutropenia in Breast Cancer
KANAKO SUZUKI, SHINSUKE SASADA, YURI KIMURA, AKIKO EMI, TAKAYUKI KADOYA and MORIHITO OKADA

Anticancer Research December 2022, 42 (12) 5945-5949; DOI: https://doi.org/10.21873/anticanres.16104
You have access
Clinical Outcome and Risk Factors of Chronic Radiation Proctitis Following Pelvic Radiation Therapy
CHAN-MUK IM, ICK-JOON CHO, HYUNG-JOO YU, BORA HAN, HYUNG-HOON OH, YOON-JIN SEO, KI-HYUN KIM, DAE-SEONG MYUNG, SUNG-BOM CHO, WAN-SIK LEE, TAEK-KEUN NAM and YOUNG-EUN JOO

Anticancer Research December 2022, 42 (12) 5951-5959; DOI: https://doi.org/10.21873/anticanres.16105
You have access
Impact of Corticosteroids for IrAEs on the Clinical Outcome of Immunotherapy in Patients With NSCLC
KAZUHIRO SHIMOMURA, TEPPEI YAMAGUCHI, YUKO OYA, KOSAKU UCHIDA and KENTA MUROTANI

Anticancer Research December 2022, 42 (12) 5961-5969; DOI: https://doi.org/10.21873/anticanres.16106
You have access
Impact of Osteopenia on Pancreatic Fistula in Patients Undergoing Pancreaticoduodenectomy
TAKAHIRO YAMANAKA, NORIFUMI HARIMOTO, RYO MURANUSHI, KOUKI HOSHINO, KEI HAGIWARA, NORIHIRO ISHII, MARIKO TSUKAGOSHI, AKIRA WATANABE, KENICHIRO ARAKI and KEN SHIRABE

Anticancer Research December 2022, 42 (12) 5971-5976; DOI: https://doi.org/10.21873/anticanres.16107
You have access
Detailed Surgical Techniques and Short-term Clinical Outcomes of Sleeve Lobectomy for Locally Advanced Right Lower Lobe Lung Cancer
TAKUMA TSUKIOKA, NOBUHIRO IZUMI, HIROAKI KOMATSU, HIDETOSHI INOUE, RYUICHI ITO, SATOSHI SUZUKI and NORITOSHI NISHIYAMA

Anticancer Research December 2022, 42 (12) 5977-5982; DOI: https://doi.org/10.21873/anticanres.16108
You have access
Impact of Abdominal Aortic Calcification After Major Hepatobiliary Pancreatic Surgery: A Retrospective Cohort Study
YUKI IMAOKA, MASAHIRO OHIRA, KOKI SATO, KOUKI IMAOKA, TOMOAKI BEKKI, RYOSUKE NAKANO, SHINTARO KURODA, HIROYUKI TAHARA, KENTARO IDE, TSUYOSHI KOBAYASHI, YUKA TANAKA and HIDEKI OHDAN

Anticancer Research December 2022, 42 (12) 5983-5989; DOI: https://doi.org/10.21873/anticanres.16109
You have access
Definitive Radiotherapy Using Electron Beam and Intensity-modulated Radiotherapy for Unresectable Angiosarcoma of the Scalp
NAOKO OKANO, HIKARU YUMISAKI, SHINTARO SAITO, NOBUTERU KUBO, KOHEI OKADA, HIDEMASA KAWAMURA, MASAHITO YASUDA and TATSUYA OHNO

Anticancer Research December 2022, 42 (12) 5991-5997; DOI: https://doi.org/10.21873/anticanres.16110
You have access
Modified Geriatric Nutrition Risk Index as a Prognostic Predictor for Unresectable/Recurrent Esophageal Cancer
KEITA KOUZU, HIRONORI TSUJIMOTO, NAOYUKI UEHATA, YUSUKE ISHIBASHI, YOJI KISHI and HIDEKI UENO

Anticancer Research December 2022, 42 (12) 5999-6006; DOI: https://doi.org/10.21873/anticanres.16111
You have access
Impact of Post-progression Survival on Outcomes of Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma: A Systematic Review and Retrospective Cohort Study
KAZUTO TAJIRI, YOSHIHARU TOKIMITSU, KENGO KAWAI, YUCHI MOTOFUJI, EIJI SHINNO, YOSHIRO KASHII, NOZOMU MURAISHI, AIKO MURAYAMA, YUKA HAYASHI, MASAMI MINEMURA, TERUMI TAKAHARA, YUKIHIRO SHIMIZU and ICHIRO YASUDA

Anticancer Research December 2022, 42 (12) 6007-6018; DOI: https://doi.org/10.21873/anticanres.16112
You have access
Prognostic Nutrition Index as an Indicator of Therapeutic Response to Lenvatinib Therapy in Hepatocellular Carcinoma
MASAHITO SHIBANO, KATSUYUKI TAKAHASHI, MASAYA TAKAHASHI, SAWAKO UCHIDA-KOBAYASHI, NORIFUMI KAWADA, YASUTAKA NAKAMURA, TORU OTORI and KATSUYA NAGAYAMA

Anticancer Research December 2022, 42 (12) 6019-6026; DOI: https://doi.org/10.21873/anticanres.16113
You have access
Risk of Abemaciclib-induced Liver Injury in Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer: A Retrospective Analysis
AZUSA TANIGUCHI, NOBUYOSHI KITTAKA, HARUKA KANAOKA, SATOMI NAKAJIMA, YURI OYAMA, YUKIKO SETO, AI SOMA, HIROKI KUSAMA, NORIYUKI WATANABE, SAKI MATSUI, MINAKO NISHIO, FUMIE FUJISAWA and TAKAHIRO NAKAYAMA

Anticancer Research December 2022, 42 (12) 6027-6035; DOI: https://doi.org/10.21873/anticanres.16114
You have access
Correlation Between Tumor Uptake on FDG-PET and Malignant Features in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by Surgery
YOICHI HAMAI, MANABU EMI, YUTA IBUKI, TOMOAKI KUROKAWA, TORU YOSHIKAWA, MANATO OHSAWA, RYOSUKE HIROHATA, NAO KITASAKI and MORIHITO OKADA

Anticancer Research December 2022, 42 (12) 6037-6045; DOI: https://doi.org/10.21873/anticanres.16115
You have access
Treatment Outcomes and Prognostic Factors of Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and Fluorouracil in Advanced Head and Neck Cancer
TAKAHIRO KUSAKA, KIYOTO SHIGA, KATSUNORI KATAGIRI, DAISUKE SAITO, SHIN-ICHI OIKAWA, AYA IKEDA, KODAI TSUCHIDA, JUN MIYAGUCHI, YU OHASHI, HISANORI ARIGA and KOZO TANNO

Anticancer Research December 2022, 42 (12) 6047-6056; DOI: https://doi.org/10.21873/anticanres.16116
You have access
Association of ABC and RENAL Scoring Systems With Morbidity in Partial Nephrectomy
MIGUEL E. JIMÉNEZ ROMERO, ISABEL BUENO GONZÁLEZ, MIGUEL A. SÁNCHEZ HURTADO, JOSÉ CARLOS RODRÍGUEZ BOCANEGRA and JOSÉ D. SANTOTORIBIO

Anticancer Research December 2022, 42 (12) 6057-6062; DOI: https://doi.org/10.21873/anticanres.16117
You have access
First-Line Gemcitabine, Nab-Paclitaxel, and Oxaliplatin Chemotherapy With Itraconazole in Patients With Metastatic Pancreatic Cancer: A Single Institution Experience
MIYUKI SAWASAKI, HIROSHI TSUBAMOTO, AYAKO SUGIHARA, SHINICHI IKUTA, YOSHIYUKI SAKAI, YUKIO OSAKI and TAKASHI SONODA

Anticancer Research December 2022, 42 (12) 6063-6069; DOI: https://doi.org/10.21873/anticanres.16118
You have access
Predictive Factors of Febrile Neutropenia After Primary Prophylactic Pegfilgrastim With DCF Chemotherapy for Esophageal Cancer
TAKAHITO INAGAKI, MIKI SATO, MASAOKI KIN, KOJI OTSUKA, MASAHIKO MURAKAMI and MARI KOGO

Anticancer Research December 2022, 42 (12) 6071-6081; DOI: https://doi.org/10.21873/anticanres.16119
You have access
Bendamustine Plus Rituximab for Mantle Cell Lymphoma: A Korean, Multicenter Retrospective Analysis
JUN HO YI, SEOK JIN KIM, JEONG-OK LEE, GYEONG-WON LEE, JAE-YONG KWAK, HYEON-SEOK EOM, JAE-CHEOL JO, YOON SEOK CHOI, SUNG YONG OH and WON SEOG KIM

Anticancer Research December 2022, 42 (12) 6083-6089; DOI: https://doi.org/10.21873/anticanres.16120
You have access
Clinical Benefit of Bevacizumab and Irinotecan (BEV+IRI) in Patients With Relapsed/Refractory Glioblastoma (r/rGBM) and its Potential Predictors
JI HYUN PARK, HYUN SEOK LEE, JIN WOO CHOI, SO DUG LIM, HYEON KANG KOH, KYUNG RAE CHO, JOON CHO, YOUNG-CHO KOH and SO YOUNG YOON

Anticancer Research December 2022, 42 (12) 6091-6098; DOI: https://doi.org/10.21873/anticanres.16121
You have access
Safety and Efficacy of Palliative Radiotherapy (25 Gy × 5 Fractions) for Symptomatic Pelvic Tumors
TOMOMI AOSHIKA, TAKANORI ABE, MISAKI IINO, SATOSHI SAITO, YASUHIRO RYUNO, TOMOHIRO OHTA, MITSUNOBU IGARI, RYUTA HIRAI, YU KUMAZAKI, SHIN-EI NODA and SHINGO KATO

Anticancer Research December 2022, 42 (12) 6099-6103; DOI: https://doi.org/10.21873/anticanres.16122
You have access
A Multi-institutional Study to Diagnose the Risk of Lymph Node Metastasis Using a CRP Genetic Polymorphism Test Kit in pT1, cN0 Thoracic Esophageal Squamous Cell Carcinoma
SATORU MOTOYAMA, MIKI HOSAKA, TAKASHI KAMEI, MASAKI UENO, MASAYUKI WATANABE, YU OHKURA, SHINJI MINE, SHUNSUKE TANABE, TAKAHIRO TOYOKAWA, AKIYUKI WAKITA, KATSUNORI NISHIKAWA, ITASU NINOMIYA, KAZUMA FUJITA, MIE KANDA, MITSUHARU HIRAI, MANAMI HOSHI, SHIH-WEI CHIU, MUNENORI TAKATA, TAKUHIRO YAMAGUCHI and MASATOMO MIURA

Anticancer Research December 2022, 42 (12) 6105-6112; DOI: https://doi.org/10.21873/anticanres.16123
You have access
Overall Survival of Small-cell Lung Cancer Patients With Malignant Central Airway Obstruction Who Received Chemotherapy Without Undergoing Transbronchial Interventions: A Single-institution Retrospective Study
KOSUKE KASHIWABARA, SHINJI FUJII, SHINSUKE TSUMURA and KAZUHIKO SAKAMOTO

Anticancer Research December 2022, 42 (12) 6113-6119; DOI: https://doi.org/10.21873/anticanres.16124
You have access
Unusual Findings in a Patient With Carney Complex due to a Novel PRKAR1A Mutation
REINHARD E. FRIEDRICH and MARTIN ZENKER

Anticancer Research December 2022, 42 (12) 6121-6125; DOI: https://doi.org/10.21873/anticanres.16125
You have access
Prospective Observational Study of Sorafenib in Hepatocellular Carcinoma Patients With Very High Risk of Recurrence After Surgery
SATORU SEO, ETSURO HATANO, MASASHI KANAI, KOHEI OGAWA, YASUTSUGU TAKADA, SHOGO KOBAYASHI, HIDETOSHI EGUCHI, HIROAKI NAGANO and TATSUYA IOKA

Anticancer Research December 2022, 42 (12) 6127-6134; DOI: https://doi.org/10.21873/anticanres.16126

Corrigenda

Open Access
Corrigendum
Anticancer Research December 2022, 42 (12) 6135;

Index

Open Access
Index
Anticancer Research December 2022, 42 (12) 6137-6308;

Main menu

User menu

Search

Table of Contents

Review

Experimental Studies

Clinical Studies

Corrigenda

Index

In this issue

Issue highlights

Jump to